Global Anti-obesity Drugs Market By Drug Type (Prescription Drugs, OTC Drugs), By Mechanism of Action (Centrally Acting Drugs, Peripherally Acting Drugs, Gut-Hormone Incretins- GLP-1 Agonists, Dual Agonists/GIP Agonists), By Route of Administration (Oral, Injectable), By Patient Type (Adults, Pediatrics), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: June 2025
- Report ID: 151652
- Number of Pages: 341
- Format:
-
-
-
- Novo Nordisk A/S Company Profile
- Eli Lilly and Company
- Hoffmann-La Roche AG
- Pfizer Inc Company Profile
- GSK plc
- Currax Pharmaceuticals LLC
- Boehringer Ingelheim International GmbH
- Amgen Inc.
- AstraZeneca Plc Company Profile
- Merck & Co., Inc.
- Zealand Pharma
- Takeda Pharmaceutical Co. Ltd
- Rhythm Pharmaceuticals, Inc.
- Vivus LLC
- Zydus Lifesciences Ltd.
- Gelesis Holdings Inc.
- Teva Pharmaceuticals Company Limited
- Hanmi Pharm.Co.,Ltd.
- Verdiva
- HK inno.N Corp.
- Dr. Reddys Laboratories Ltd Company Profile
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible